Spruce Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRB and other ETFs, options, and stocks.

About SPRB

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont.

CEO

Javier Szwarcberg

CEOJavier Szwarcberg

Employees

Employees21

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2014

Founded2014

Employees

Employees21

SPRB Key Statistics

Market cap

6.03M

Market cap6.03M

Price-Earnings ratio

-0.11

Price-Earnings ratio-0.11

Dividend yield

—

Dividend yield—

Average volume

4.82M

Average volume4.82M

High today

$0.1409

High today$0.1409

Low today

$0.128

Low today$0.128

Open price

$0.1346

Open price$0.1346

Volume

2.32M

Volume2.32M

52 Week high

$0.87

52 Week high$0.87

52 Week low

$0.11

52 Week low$0.11

Spruce Biosciences

Why Robinhood?

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont. Show more

SPRB Key Statistics

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont.